BioNTech tests new weapon in fight against HIV
NCT ID NCT07392372
Summary
This is a first-in-human study to test the safety and blood levels of a new antibody called BNT351. It will involve 61 adults, both with and without HIV, to see if the antibody is safe and if it can reduce the amount of HIV in the blood of those living with the virus. The study is in its earliest phase, focusing primarily on safety and how the body processes the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CRS Mannheim
RECRUITINGMannheim, 68167, Germany
-
UK Köln
NOT_YET_RECRUITINGCologne, 50937, Germany
Conditions
Explore the condition pages connected to this study.